Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXI9CX
|
||||
Drug Name |
4-(5-{[2-(2-Methyl-benzyl)-3-oxo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-ylamino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL165895
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C30H29N5O
|
||||
Canonical SMILES |
Cc1ccccc1CN2Cc3ccccc3CC(NCc4cncn4Cc5ccc(cc5)C#N)C2=O
|
||||
InChI |
InChI=1S/C30H29N5O/c1-22-6-2-3-8-26(22)19-34-20-27-9-5-4-7-25(27)14-29(30(34)36)33-17-28-16-32-21-35(28)18-24-12-10-23(15-31)11-13-24/h2-13,16,21,29,33H,14,17-20H2,1H3
|
||||
InChIKey |
JHSZMWDOIIIMSL-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.